Skip to main content

Table 3 Patient characteristics per chart audit

From: Healthcare professionals’ perceptions on the emotional impact of having an inadequate response to antidepressant medications: survey and prospective patient audit

Variable Statistic
N = 1336
Setting
 Office 802 (60%)
 (US only) Outpatient Community Health Clinic 75 (6%)
 (France only) Centre Medical Psychologique 53 (4%)
 Hospital Outpatient Clinic 351 (26%)
 Telemedicine 12 (1%)
 Patient’s Home 23 (2%)
 Day Clinic 19 (1%)
 Other 1 (< 1%)
Length of MDD diagnosis
 < 1 month 88 (7%)
 1–3 months 174 (13%)
 4–6 months 180 (14%)
 7–9 months 65 (5%)
 10–12 months 211 (16%)
 2–5 years 370 (28%)
 6 + years 248 (19%)
Current treatment
 SSRI 800 (60%)
 SNRI 320 (24%)
 MAOI 7 (< 1%)
 TCA 49 (4%)
 Other antidepressant 295 (22%)
 Anxiolytic 239 (18%)
 Antipsychotic 243 (18%)
 Hypnotic 76 (6%)
 Other treatment for depression 69 (5%)
Mean current ADT duration by treatment class (weeks)
 SSRI 45.4
 SNRI 48.7
 MAOI 22.0
 TCA 106.8
 Other antidepressant 38.9
Number of current classes of prescription treatments for depression (this episode); n (%)
 0 6 (< 1%)
 1 755 (57%)
 2 397 (30%)
 3 145 (11%)
 4 28 (2%)
 5 + 5 (< 1%)
 Mean number 1.6
Level of functioning (mean SDS scores)
 SDS Mean score 5.1
 Work domain 6.0
 Social domain 4.7
 Home domain 4.5
PHQ-9 score (mean) 6.2
Clinical global impression of change in depression since onset of episode to current visit
 Very much worse 5 (< 1%)
 Much worse 63 (5%)
 Minimally worse 113 (9%)
 No change 248 (19%)
 Minimally improved 413 (31%)
 Much improved 400 (30%)
 Very much improved 94 (7%)